U.S. Hospitality Stock News

NYSE:BW
NYSE:BWElectrical

A Look At Babcock & Wilcox (BW) Valuation As Legal And Earnings Concerns Shape Sentiment

Babcock & Wilcox Enterprises (BW) is back in focus after securing more than US$21 million in new fuel switching awards, just as legal and earnings concerns keep pressure on how investors view the stock. See our latest analysis for Babcock & Wilcox Enterprises. At a latest share price of US$15.55, BW has a 7 day share price return of 5.21% but a 30 day share price return of negative 7.16%. The 90 day share price return of 82.51% and very large 1 year total shareholder return suggest strong...
NYSE:ACHR
NYSE:ACHRAerospace & Defense

Is It Time To Reassess Archer Aviation (ACHR) After Recent Electric Air Taxi Progress?

If you are wondering whether Archer Aviation stock offers good value or just fresh hype, you need to look past the headlines and consider how its current price lines up with a few core valuation checks. The stock last closed at US$6.41, with returns of 14.5% over 7 days, 15.7% over 30 days, a 21.2% decline year to date and a 25.1% decline over 1 year. This points to shifting sentiment and risk perceptions over different time frames. Recent news coverage around Archer Aviation has focused on...
NYSE:HWM
NYSE:HWMAerospace & Defense

Howmet Aerospace Deepens Defense Focus With Consolidated Aerospace Manufacturing Deal

Howmet Aerospace (NYSE:HWM) plans to acquire Consolidated Aerospace Manufacturing Defense Group. The transaction is aimed at expanding Howmet's defense focused product offerings. The deal marks a material step for Howmet in broadening exposure to defense and space related components. For investors following NYSE:HWM, this move reflects the company’s focus on aerospace and defense components at a time when governments worldwide are committing substantial budgets to military and space...
NYSE:PRU
NYSE:PRUInsurance

Prudential Financial (PRU) Margin Improvement Challenges Longstanding Earnings Skepticism In Latest Results

Prudential Financial (PRU) opened 2026 with Q1 revenue of US$14.3b and basic EPS of US$1.69 on net income of US$588m, setting a clear marker for how the year is starting to shape up. Over recent quarters, the company has seen revenue move from US$13.5b and EPS of US$1.97 in Q1 2025 to US$16.2b and EPS of US$2.56 in Q4 2025, with trailing twelve month EPS at US$9.78 on net income of US$3.4b across US$62.6b of revenue. For investors, the key question now is how these earnings and a 5.5%...
NasdaqGS:STBA
NasdaqGS:STBABanks

A Look At S&T Bancorp (STBA) Valuation After Recent Share Price Moves

Context for S&T Bancorp stock S&T Bancorp (STBA) has drawn investor attention after recent share price moves, with the stock last closing at $44.54 and showing mixed short term returns over the past week, month, and past 3 months. See our latest analysis for S&T Bancorp. For context, S&T Bancorp’s recent 1-month share price return of 3.68% and year to date share price return of 13.51% sit alongside a 1-year total shareholder return of 24.33%, suggesting momentum that has been building rather...
NYSE:BFAM
NYSE:BFAMConsumer Services

Bright Horizons Q1 EPS Holds Firm As Margin Story Supports Bullish Narratives

Bright Horizons Family Solutions (BFAM) has opened 2026 with Q1 results showing revenue of US$712.2 million and basic EPS of US$0.63, alongside trailing twelve month revenue of US$3.0 billion and EPS of US$3.37. Over the past year, quarterly revenue has ranged from US$665.5 million to US$802.8 million, while EPS has moved between US$0.39 and US$1.38. This provides a clear view of how the top and bottom lines have tracked into the latest print. With trailing net profit margin at 6.3%,...
NasdaqGS:AAL
NasdaqGS:AALAirlines

Is It Time To Reassess American Airlines Group (AAL) After Its Recent Share Price Rebound

If you are wondering whether American Airlines Group is starting to look attractively priced, or if the risks still outweigh the potential upside, this article breaks down what the current share price may be implying about value. The stock last closed at US$12.94, with recent returns of 14.4% over 7 days, 18.7% over 30 days, 22.5% over 1 year and a year-to-date return of a 16.4% decline, which gives mixed signals on how the market has been reassessing it over different time frames. Recent...
NasdaqGM:APPN
NasdaqGM:APPNSoftware

Appian (APPN) Valuation Check As New AI Platform Updates And Snowflake Partnership Draw Market Attention

Appian (APPN) has just rolled out a broad refresh of its Appian Platform, highlighting AI assisted spec driven development, expanded Model Context Protocol integration, and a new Snowflake partnership that ties directly into Snowflake's AI Data Cloud. See our latest analysis for Appian. The recent platform updates and the new Snowflake partnership come as momentum in the share price has been mixed, with a 6.72% 7 day share price return, a 31.94% year to date share price decline, and a 71.96%...
NasdaqGS:CSX
NasdaqGS:CSXTransportation

Is It Too Late To Consider CSX (CSX) After A 60% One Year Rally?

If you are wondering whether CSX is still fairly priced after a strong run, this article walks through what the current share price might be implying about the stock's value. CSX's stock closed at US$45.60, with returns of 0.4% over the last 7 days, 10.1% over 30 days, 25.7% year to date and 59.9% over the past year. This performance has likely caught the attention of investors assessing both opportunity and risk. Recent coverage has focused on CSX's position within U.S. rail transportation,...
NYSE:SUN
NYSE:SUNOil and Gas

The Bull Case For Sunoco (SUN) Could Change Following Acquisition-Fueled Q1 2026 Earnings Surge - Learn Why

Sunoco LP recently reported past first-quarter 2026 results showing sales of US$10,690 million and net income of US$644 million, with basic earnings per share from continuing operations of US$2.86. Management highlighted that acquisitions like Parkland and Tankwood, a large one-time inventory optimization benefit, and a higher quarterly distribution have made the business, in their view, stronger and more accretive than ever. Next, we’ll examine how Sunoco’s strong earnings, boosted by...
NYSE:AES
NYSE:AESRenewable Energy

AES (AES) Q1 EPS Jump Challenges Bearish Views On Profitability Sustainability

AES (AES) opened 2026 with Q1 revenue of US$3.2b and basic EPS of US$0.68, setting the tone for how investors will read the latest numbers against its recent track record. The company has seen quarterly revenue move from US$2.9b in Q1 2025 to US$3.2b in Q1 2026, while basic EPS shifted from US$0.06 to US$0.68 over the same period, against a trailing twelve month EPS of US$1.94. With a trailing net profit margin of 11.1%, slightly above last year, this set of results lands in a context of...
NYSE:BBY
NYSE:BBYSpecialty Retail

Best Buy (BBY) Valuation Check As New Membership Rewards Program Targets Loyal Shoppers

Best Buy (BBY) has put its membership program in the spotlight, announcing a new rewards points system for My Best Buy Plus and Total members that ties everyday electronics spending more directly to future discounts. See our latest analysis for Best Buy. Those membership changes land at a time when the stock has a 1-day share price return of 2.48% to US$58.69 but a 30-day share price return of an 8.58% decline and a 1-year total shareholder return of a 9.33% decline, suggesting momentum has...
NasdaqGS:VRTX
NasdaqGS:VRTXBiotechs

How Investors May Respond To Vertex (VRTX) Reaffirming 2026 Guidance Amid CF And Gene Therapy Advances

In early May 2026, Vertex Pharmaceuticals reported past first-quarter 2026 results showing revenue of US$2,986.9 million and net income of US$1,031.4 million, alongside reaffirmed full-year revenue guidance of US$12.95 billion to US$13.10 billion. The quarter also underscored Vertex’s push beyond cystic fibrosis, with expanding access to CASGEVY gene therapy and progress in its emerging renal franchise, including regulatory momentum for povitacicept in IgA nephropathy. We’ll now examine how...
NYSE:LLY
NYSE:LLYPharmaceuticals

Is Eli Lilly (LLY) Still Attractive After Its Near US$1,000 Share Price Surge

If you are wondering whether Eli Lilly's near US$1,000 share price still offers value, you are not alone. The numbers give you plenty to think about. The stock recently closed at US$987.05, with returns of 16.0% over 7 days, 6.5% over 30 days, a year to date return of an 8.6% decline, and 28.0% over 1 year, plus a very large 3 year gain and a roughly 4x return over 5 years. Recent headlines have focused heavily on Eli Lilly's pipeline and high profile therapies, which have kept the stock...
NYSE:IBM
NYSE:IBMIT

A Look At IBM (IBM) Valuation After Recent Pullback And Long Term Return Profile

Recent Share Performance and Business Mix International Business Machines (IBM) has drawn investor attention after a recent pullback, with the stock showing negative returns over the past month and past 3 months and sitting below its year to date level. At a last close of US$225.74 and a market value of about US$215.3b, the company combines sizeable revenue from software, consulting, infrastructure and financing. This provides several business drivers to watch within a single stock. See our...
NasdaqCM:EOSE
NasdaqCM:EOSEElectrical

A Look At Eos Energy Enterprises (EOSE) Valuation After EPS Beat Hopes And New CFO Appointment

Recent interest in Eos Energy Enterprises (EOSE) has been shaped by expectations for an upcoming earnings per share surprise and the appointment of experienced finance leader Alessandro Lagi as Chief Financial Officer. See our latest analysis for Eos Energy Enterprises. The recent excitement around earnings expectations and the CFO appointment comes after a mixed price pattern, with a 46.9% 90 day share price decline contrasting with a 46.0% 30 day share price return and a very large 3 year...
NasdaqGM:TMDX
NasdaqGM:TMDXMedical Equipment

TransMedics Group (TMDX) Q1 EPS Lull Tests Bullish Profitability Narratives

Q1 2026 earnings snapshot TransMedics Group (TMDX) has just posted Q1 2026 results with revenue of US$173.9 million, basic EPS of US$0.21 and net income of US$7.3 million, set against a current share price of US$72.92. The company has reported revenue of US$121.6 million in Q4 2024 and US$173.9 million in Q1 2026, while quarterly basic EPS moved from US$0.20 to US$0.21 over the same span. With trailing earnings growth and a higher net profit margin in the background, this quarter’s numbers...
NYSE:TIC
NYSE:TICProfessional Services

Why TIC Solutions (TIC) Is Up 14.3% After Record NV5-Driven Q1 Sales But Wider Loss

TIC Solutions, Inc. reported first-quarter 2026 results, with sales rising to US$488.03 million from US$234.22 million a year earlier, while net loss widened to US$41.55 million. The quarter highlighted the impact of the NV5 Global acquisition, as record revenue and reaffirmed 2026 guidance contrasted with continued losses and higher financing costs. We’ll now examine how the record NV5-driven revenue and reaffirmed 2026 outlook reshape TIC Solutions’ longer-term investment narrative. The...
NasdaqCM:PLSE
NasdaqCM:PLSEMedical Equipment

What Pulse Biosciences (PLSE)'s Mixed Q1 Results and nPulse AF Data Reveal for Shareholders

Pulse Biosciences recently reported first-quarter 2026 results showing a wider net loss of US$18.58 million and basic loss per share of US$0.27, while also missing consensus revenue expectations with about US$0.4 million in sales. At the same time, the company released late-breaking, positive first-in-human data for its nPulse Cardiac Catheter System in atrial fibrillation, reinforcing confidence in its non-thermal nsPFA platform with high procedural success, durable rhythm control and a low...
NYSE:CVS
NYSE:CVSHealthcare

CVS Health (CVS) Q1 2026 Margin Compression And One Off Loss Test Bullish Narratives

CVS Health (CVS) opened 2026 with Q1 revenue of about US$100.4 billion and basic EPS of US$2.31, setting the tone for this reporting season. The company has seen quarterly revenue move from US$94.1 billion in Q1 2025 to US$100.4 billion in Q1 2026, while basic EPS over the same quarters shifted from US$1.41 to US$2.31, and trailing twelve month EPS now sits at roughly US$2.31 on revenue of US$405.7 billion. With reported net margins over the last year sitting at 0.7% and influenced by a large...
NYSE:LEVI
NYSE:LEVILuxury

Is It Too Late To Consider Levi Strauss (LEVI) After Its 1 Year 42.8% Rally?

If you are wondering whether Levi Strauss stock still offers value after its recent run, or if you may be late to the party, this article breaks down what the current price might be implying about the company. With the share price at US$23.03 and returns of 5.2% over 7 days, 17.2% over 30 days, 10.6% year to date and 42.8% over 1 year, many investors are questioning what is already priced in. Those moves sit alongside a longer record, with returns of 83.4% over 3 years but a 4.9% decline...
NYSE:NEXA
NYSE:NEXAMetals and Mining

Nexa Resources (NEXA) Is Up 18.1% After Cerro Lindo Stream Step-Down Boosts Earnings Flexibility – Has The Bull Case Changed?

Nexa Resources has already reported a strong first quarter of 2026, with net revenues rising to about US$888 million and net income reaching US$118 million on the back of higher metal prices, stronger smelting volumes, and resolved disruptions in Peru. A key shift was the Cerro Lindo silver streaming step-down, which cut the streamed share from 65% to 25% after a delivery threshold, allowing Nexa to retain and sell an additional 1.2–1.3 million ounces of silver at spot prices from the second...
NYSE:AMC
NYSE:AMCEntertainment

AMC Entertainment (AMC) Q1 Losses Keep Pressure On Bullish Margin Expansion Narratives

AMC Entertainment Holdings (AMC) opened Q1 2026 with revenue of US$1,045.4 million and a basic EPS loss of US$0.22, compared with Q1 2025 revenue of US$862.5 million and a basic EPS loss of US$0.47 as the stock trades around US$1.64. Over the past year, revenue has ranged between US$862.5 million and US$1,397.9 million per quarter, while quarterly basic EPS losses have moved between roughly US$0.01 and US$0.58, leaving investors focused on how much of that top line is dropping through to the...
NYSE:KOS
NYSE:KOSOil and Gas

Kosmos Energy Reshapes Portfolio With Asset Sale And Capital Raises

Kosmos Energy (NYSE:KOS) reports record production in Q1 2026, linked to the GTA and Jubilee field expansions. The company announces a US$350 million bond issue and a US$200 million equity raise, with proceeds aimed at reducing debt. Kosmos agrees to sell its Equatorial Guinea assets for up to US$220 million, while also taking final investment decision on the Tiberius project. These operational and financing actions come alongside ongoing losses and amount to a broad portfolio and balance...